Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Phase II Study of Carboplatin Combined with Biweekly Docetaxel for Advanced Non-small Cell Lung Cancer

Phase II Study of Carboplatin Combined with Biweekly Docetaxel for Advanced Non-small Cell Lung... Biweekly docetaxel plus carboplatin has a similar efficacy and lower toxicity compared with a standard triweekly regimen of docetaxel plus carboplatin, which is a suitable regimen for outpatients, including elderly patients. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Thoracic Oncology Wolters Kluwer Health

Phase II Study of Carboplatin Combined with Biweekly Docetaxel for Advanced Non-small Cell Lung Cancer

Journal of Thoracic Oncology , Volume 1 (9) – Nov 1, 2006

Loading next page...
 
/lp/wolters-kluwer-health/phase-ii-study-of-carboplatin-combined-with-biweekly-docetaxel-for-Oz5vN2nnNu

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1556-0864

Abstract

Biweekly docetaxel plus carboplatin has a similar efficacy and lower toxicity compared with a standard triweekly regimen of docetaxel plus carboplatin, which is a suitable regimen for outpatients, including elderly patients.

Journal

Journal of Thoracic OncologyWolters Kluwer Health

Published: Nov 1, 2006

There are no references for this article.